510(k) device
TrabEx Pro
Microsurgical Technologies, Inc. · Pump, Infusion, Ophthalmic (MRH, Class II) · First FDA decision Jun 8, 2022, newest Jun 8, 2022Glaucoma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
0
Naming "TrabEx Pro"
MAUDE reports
1
Brand "TrabEx Pro", since 2015
PubMed studies
0
Mentioning "TrabEx Pro"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TrabEx Pro
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- TrabEx Pro510(k)
K213173 · Decided Jun 8, 2022 · 253 days after receipt
Device type: Pump, Infusion, Ophthalmic (MRH) · Hospital Medicine & Nursing
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TrabEx Pro", any status and sponsor, newest update first.
No registered device study names "TrabEx Pro".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TrabEx Pro", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code MRH
140 reports: 44 malfunction, 95 injury, 0 death
Newest reports for this brand
- TRABEX PROInjury
MICROSURGICAL TECHNOLOGY, INC.
3019924-2023-00001 · Received Jul 26, 2023 · Event dated Jan 3, 2023
Device type: Pump, Infusion, Ophthalmic (MRH)
Device problem as coded: Use of Incorrect Control/Treatment Settings
Patient problem as coded: Eye Injury
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TrabEx Pro"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MRH.
- OMNI Surgical SystemSight Sciences, Inc. · 510(k) 2023
- Viscoelastic InjectorSight Sciences, Inc. · 510(k) 2014
- OMNI Ultra Surgical System (1-110)Sight Sciences, Inc. · 510(k) 2026
- VIA360 Surgical SystemNew World Medical, Inc. · 510(k) 2025
- iPrime Viscodelivery SystemGlaukos · 510(k) 2022
- Streamline Surgical SystemNew World Medical, Inc. · 510(k) 2021
- OMNI PLUS Surgical SystemSight Sciences, Inc. · 510(k) 2020
- VISCO 360 Viscosurgical SystemSight Sciences, Inc. · 510(k) 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.